At meeting held on 03 October 2015
Krebs Biochemicals & Industries announced the Board of Directors of the Company at its meeting held on 03 October 2015, inter alia, has considered and approved the following items of business:- Allotment of 650,000 equity shares of face value of Rs. 10/- each at a price of Rs. 54/- per share (including premium of Rs. 44/- per share) and 680,000 convertible warrants each of which is convertible into one equity share of face value of Rs. 10/- at a price of Rs. 54/- per share (including premium of Rs. 44/- per share) on preferential basis to Hemalata Ravi, Promoter of the Company.
Powered by Capital Market - Live News
